Texas-based McKesson Corp., which acquired Rexall in 2016 for $2.9 billion, has been talking to prospective buyers, sources told The Globe and Mail. In an email to The Logic, McKesson declined to comment on what it called rumours or speculation. (The Globe and Mail, The Logic)
Talking point: Rexall has about 400 pharmacies in Canada and 8,000 employees, according to its website. Its possible buyers include rival chains and private equity firms, according to The Globe. Rexall has struggled in a challenging industry with low profit margins. Shortly after the acquisition, new Canadian regulations slashed generic drug prices and minimum wages rose in some provinces, leading Rexall to shutter nearly 10 per cent of its locations and McKesson to take a large impairment charge related partly to the pharmacy business.